Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleInhibiting TET1 alleviates non‐alcoholic liver disease progression by targeting lipid metabolic pathways.AuthorsMulla, Joud; Nagaoka, Katsuya; Cao, Kevin; Cheng, Zhixiang; Bai, Xuewei; Zhang, Hongyu; Ji, Chengcheng; Lu, Shaolei; Huang, Chiung‐KueiPublicationFASEB Journal, 2022, Vol 36, pN.PAGISSN0892-6638Publication typeArticleDOI10.1096/fasebj.2022.36.S1.0R520